Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving
- PMID: 19172249
- PMCID: PMC3697848
- DOI: 10.1007/s00213-009-1472-0
Abnormal pain response in pain-sensitive opiate addicts after prolonged abstinence predicts increased drug craving
Abstract
Rationale: Craving is a primary feature of opiate addiction and is clinically significant because of its potential to trigger opiate use and relapse. Opiate use can also produce abnormal pain perception. We predicted that for opiate addicts (OAs), there may be an association between these two major features of addiction (drug craving and abnormal pain responses).
Objectives: To examine pain responses in abstinent opiate addicts in comparison with healthy controls using a cold-pressor test (CPT) and investigate the correlations of cue-induced drug craving with pain responses.
Material and methods: Fifty-four abstinent OAs and 46 healthy subjects participated in the CPT, and the OAs were also exposed to heroin-related cues the day before the pain test. Outcome measures included pain-tolerance time, VAS ratings of pain intensity and distress, and (in the cue-exposure procedure) VAS ratings of heroin craving and anxiety.
Results: In the CPT, abstinent addicts showed shorter pain-tolerance time (85.1 +/- 14.1 s vs. 133.7 +/- 16.7 s, p < 0.05) and higher ratings of pain distress (61 +/- 3.2 vs. 45.6 +/- 3.2, p < 0.01) compared to healthy controls. When we divided the addicts and controls into pain-sensitive (PS) and pain-tolerant (PT) groups by dichotomizing each group in terms of pain-tolerance time, we again found differences between the two PS groups (37.3 +/- 3.5 s vs. 57.4 +/- 5.1 s, p < 0.01 for pain-tolerance time; 66.7 +/- 3.2 vs. 52.4 +/- 3.3, p < 0.01 for distress ratings). For all participants, pain-tolerance time was negatively correlated with VAS ratings for pain intensity and distress. More importantly, the PS addicts reported greater cue-induced craving than the PT addicts (17.8 +/- 2.2 vs. 4.5 +/- 4.2, p < 0.05). For the addict group as a whole, pain distress (the affective aspect of pain) was positively correlated with intensity of cue-induced craving measured on a different day (r = 0.33, p = 0.01).
Conclusions: A hyperalgesic state persists for at least 5 months in abstinent OAs and is predictive of cue-induced craving. Longitudinal research is needed to clarify the direction of causation between hyperalgesia and opiate addiction.
Figures



Similar articles
-
Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects.Drug Alcohol Depend. 2006 May 20;82(3):218-23. doi: 10.1016/j.drugalcdep.2005.09.007. Epub 2005 Oct 17. Drug Alcohol Depend. 2006. PMID: 16229972
-
Diurnal variation in cue-induced responses among protracted abstinent heroin users.Pharmacol Biochem Behav. 2009 Jan;91(3):468-72. doi: 10.1016/j.pbb.2008.08.023. Epub 2008 Sep 9. Pharmacol Biochem Behav. 2009. PMID: 18809427
-
Is opioid-induced hyperalgesia reversible? A study on active and former opioid addicts and drug naïve controls.J Opioid Manag. 2012 Nov-Dec;8(6):343-9. doi: 10.5055/jom.2012.0134. J Opioid Manag. 2012. PMID: 23264312
-
Human pain responsivity in a tonic pain model: psychological determinants.Pain. 1989 May;37(2):143-160. doi: 10.1016/0304-3959(89)90126-7. Pain. 1989. PMID: 2664663 Review.
-
[Maintenance treatment of opiate addicts].Nervenarzt. 2007 Jan;78(1):103-9; quiz 110. doi: 10.1007/s00115-006-2200-1. Nervenarzt. 2007. PMID: 17180670 Review. German.
Cited by
-
Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.Am J Drug Alcohol Abuse. 2019;45(5):495-505. doi: 10.1080/00952990.2019.1620260. Epub 2019 Jun 27. Am J Drug Alcohol Abuse. 2019. PMID: 31246117 Free PMC article.
-
Genome-wide association study reveals multiple loci for nociception and opioid consumption behaviors associated with heroin vulnerability in outbred rats.Mol Psychiatry. 2025 Aug;30(8):3363-3375. doi: 10.1038/s41380-025-02922-4. Epub 2025 Feb 25. Mol Psychiatry. 2025. PMID: 40000848 Free PMC article.
-
Developing a novel treatment for patients with chronic pain and Opioid User Disorder.Subst Abuse Treat Prev Policy. 2022 May 7;17(1):35. doi: 10.1186/s13011-022-00464-4. Subst Abuse Treat Prev Policy. 2022. PMID: 35525964 Free PMC article. Clinical Trial.
-
The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.Clin J Pain. 2014 Jan;30(1):36-45. doi: 10.1097/AJP.0b013e3182851758. Clin J Pain. 2014. PMID: 23446076 Free PMC article. Clinical Trial.
-
2 Hz EA Reduces Heroin Withdrawal-Induced Hyperalgesia and Heroin Relapse by Downregulating P2X3 Receptors in DRG Neurons.Biomed Res Int. 2019 Dec 24;2019:1873859. doi: 10.1155/2019/1873859. eCollection 2019. Biomed Res Int. 2019. PMID: 31950033 Free PMC article.
References
-
- Akvardar Y, Turkcan A, Cakmak D. Is substance abuse among physicians a problem? Turk Psikiyatri Derg. 2002;13:238–244. - PubMed
-
- Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L, Gong J, Schluger J, Strong JA, Leal SM, Tischfield JA, Kreek MJ, Yu L. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998;95:9608–9613. - PMC - PubMed
-
- Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004;73:199–207. - PubMed
-
- Brooks JC, Zambreanu L, Godinez A, Craig AD, Tracey I. Somatotopic organisation of the human insula to painful heat studied with high resolution functional imaging. Neuroimage. 2005;27:201–209. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical